Opiant Pharmaceuticals Announces Top-line Results from Phase 2 Clinical Trial of OPNT001 for Treatment of Bulimia Nervosa

February 21, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search